Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2022-06-21 09:39:33
Global pharmaceutical industry leaders meet with German officials to discuss life sciences innovation in Germany and global pandemic response involving the G7
Berlin, 21 June, 2022 – Today, global leaders from the pharmaceutical industry met with German officials from the ministries of ...
Read More2022-06-17 07:12:58
Pharmaceutical industry expresses deep disappointment with decision on waiving intellectual property rights adopted at the World Trade Organization Ministerial Conference
IFPMA, the body representing biopharmaceutical companies in Geneva, expresses deep disappointment with the decision taken ...
Read More2022-05-23 08:17:57
Improving access to and use of essential life-saving cancer medicines in LLMICs
This news release was originally published by UICC on 20 May 2022. IFPMA and many ...
Read More2022-05-22 23:00:57
Pharma analysis of lessons learned from COVID-19 pandemic informs and offers shared solutions to consolidate innovation successes and improve equitable access for future pandemic response
Swift pathogen surveillance and sharing, an enabling innovation ecosystem, and regulatory agility are among the ...
Read More2022-04-26 17:00:48
Celebrating World IP Day with a focus on youth and innovation
Geneva, 26 April 2022 – On World Intellectual Property (IP) Day, the International Federation of ...
Read More2022-04-13 12:45:21
COVID-19 vaccines and treatments output continues apace; as health systems and last mile hurdles remain collective stumbling blocks
To date, over 13 billion doses of COVID-19 vaccines have been produced and 11 billion ...
Read More2022-04-04 13:49:50
Largest pharmaceutical industry-backed collective venture fund tackling antimicrobial resistance announces first portfolio investments
April 4, 2022, Geneva – The international trade body representing the biopharmaceutical industry (IFPMA) today ...
Read More
Latest Statement
2022-06-15 11:04:34
IFPMA’s comments on annotated outline of a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response
The biopharmaceutical industry has been at the forefront of the response to the current pandemic and, as a result, is ...
Read More2022-06-09 08:00:45
Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12)
April 4, 2022, Geneva – The international trade body representing ...
Read More2022-05-27 09:00:20
IFPMA and BIO Statement on Influenza Preparedness for WHA75 agenda item 17.1
April 4, 2022, Geneva – The international trade body representing ...
Read More2022-05-25 12:00:12
IFPMA, GSCF, DITTA, and GMTA Statement on NCDs for WHA75 agenda item 14.1
April 4, 2022, Geneva – The international trade body representing ...
Read More2022-05-24 08:09:34
IFPMA, GSCF, and DITTA Statement on Health Emergencies for WHA75 agenda item 16.2
April 4, 2022, Geneva – The international trade body representing ...
Read More2022-05-10 16:56:42
Open Letter on ACT-A Therapeutics and Ongoing Roadblocks to Enhancing Access
April 4, 2022, Geneva – The international trade body representing ...
Read More2022-05-10 12:25:38
IFPMA statement on Quad’s Outcome Document on TRIPS
April 4, 2022, Geneva – The international trade body representing ...
Read More
mailto:a.jones@ifpma.org
Abigail Jones - Director, Communications
Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.
mailto:m.depol@ifpma.org
Twitter @MorganePol
Morgane De Pol - Deputy Director, Communications
Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
News Release
Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential
9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of
Read MoreOur Blog
Collaboration can help find a vaccine within first 100 days
This blog was originally published on Health Awareness on 21 June 2022. We must take pandemic preparedness farther, faster by ensuring a joint response to future outbreaks. Our efforts against COVID-19 have surfaced critical learnings, including the need to establish a global foundational capability, fit for purpose ahead of the next health emergency. Key learnings for a better vaccine ecosystem We have witnessed the importance...
Read More
Vaccines are making an impact through vaccinations
This blog was originally published on Health Awareness on 21 June 2022. The challenge is not getting hold of COVID-19 vaccines, it is getting vaccines into arms. The healthcare community is continuing to showcase the value of vaccines throughout one’s life course. Over the last two years, the global healthcare community’s efforts in mounting a response to COVID-19 have materialised. This pandemic has brought home...
Read More
How do we improve clinical trials post-pandemic?
This article featured in the Media Planet Clinical Trials campaign, available online and disseminated in print with the New Scientist. The COVID-19 pandemic has taught us a lot and yet we can still keep learning. While the pandemic has impacted everyone globally in ways that could never have been imagined, it has provided a spark for further exploration into how clinical trials should be improved,...
Read MoreLatest Tweets
